Office of Disease Prevention and Health Promotion. Washington, DC: US Public Health Service; 1992.
2.
AldanaS.Financial impact of worksite health promotion and methodological quality of the evidence. Art Health Promot. 1998;2(1):1–8.
3.
ChapmanL.Proof Positive: Analysis of the Cost-Effectiveness of Wellness. 3rd ed.Seattle Wash: Summex Corporation; 1996.
4.
PelletierKR. A review and analysis of the health and cost-effectiveness outcome studies of comprehensive health promotion and disease prevention programs at the worksite. Am J Health Promot. 1996;10(5):380–388.
5.
BlairSN. Non-economic benefits of health promotion. In: KamanRL, ed. Worksite Health Promotion Economics. Champaign, Ill: Human Kinetics; 1995:33–54.
6.
CohenKVogtENaughtonD. Equating health and productivity. Business Health. 1997:23–26.
7.
LynchW. Using cost as a health promotion outcome: Problems with measuring health in dollars. In: OpatzJ, ed. Economic Impact of Worksite Health Promotion. Champaign, Ill: Human Kinetics Publishers; 1994:51–63.
8.
BaunW. The impact of worksite health promotion on absenteeism. In: KamanRL, ed. Worksite Health Promotion Economics. Champaign Ill: Human Kinetics Publishers; 1995:130–145.
9.
KnightKGoetzelRZFieldingJ. An evaluation of Duke University's LIVE FOR LIFE health promotion program on changes in worker absenteeism. J Occup Med.1994;36(5):533–536.
10.
JefferyRWForsterJLDunnBVFrenchSAMcGovernPGLandoHA. Effects of work-site health promotion on illness-related absenteeism. J Occup Med.1993;35:1142–1146.
11.
BerteraRL. The effects of behavioral risks on absenteeism and healthcare costs in the workplace. J Occup Med.1991;33:1119–1124.
12.
KingeryPEllsworthCCorbettBBowdenRBrizzolaraJ. High-cost analysis: A closer look at the case for work-site health promotion. J Occup Med.1994;36(12):1341–1347.
13.
Washington Business Group on Health. Investing in People for Corporate Growth and Success: Health and Productivity Management. Washington, DC: Washington Business Group on Health; 1998.
14.
LeveringRMoskowitzM. The 100 best companies to work for in America. Fortune. 1998:84–95.
15.
AndersonDRStaufackerMJ. The impact of worksite-based health risk appraisal on health-related outcomes: A review of the literature. Am J Health Promot. 1996;10(6):499–508.
16.
WarnerKEWickizerTMWolfeRASchildrothJESamuelsonMH. Economic implications of workplace health promotion programs: Review of the literature [Review, 27 refs]. J Occup Med.1988;30:106–112.
17.
LynchWVD. The potential impact of health promotion on health care utilization: An introduction to demand management. AWHP Practitioners' Forum. 1993;8(2):87–92.
18.
McGinnisJFoegeW. Actual causes of death in the United States. JAMA. 1993;270(19):2207–2212.
19.
Milliman & Robertson, Inc.Health Risks and Behavior; the Impact on Medical Costs. Brookfield, Wisc: Report by Control Data Corporation; 1987.
20.
Milliman & Robertson, Inc.Health Risks and Behavior; the Impact on Medical Costs. Brookfield, Wisc: Report by Chrysler Corporation; 1995.
21.
YenLTEdingtonDWWittingP. Corporate medical claim cost distributions and factors associated with high-cost status. J Occup Med.1994; 36(5):505–515.
22.
HigginsC. The economics of health promotion. Health Values. 1988;12: 39–45.
23.
YenLTEdingtonDWWittingP. Prediction of prospective medical claims and absenteeism costs for 1284 hourly workers from a manufacturing company. J Occup Med.1992;34:428–435.
24.
Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed.Baltimore, Md: Williams and Wilkins; 1995.
25.
Morbidity and Mortality Weekly Report. Cancer screening offered by worksites—United States, 1992 and 1995. MMWR Morb Mortal Wkly Rep.1997;46:421–424.
26.
LandisSMurrayTBoldenSWingoP. Cancer statistics, 1998. CA Cancer J Clin.1998;48(6):6–29.
27.
BrownMFintorL. Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature. Breast Cancer Res Treat.1993;25:113–118.
28.
KattloveHLibertatiAKeelerEBrookR. Benefits and costs of screening and treatment for early breast cancer. JAMA. 1995;273(2):142–148.
29.
LindforsKRosenquistJ. The cost-effectiveness of mammographic screening. JAMA. 1995;274(11): 881–884.
30.
SmartCHendrichRRutledgeJHSmithR. Benefit of mammography screening in women ages 40 to 49 years: Current evidence from randomized trials. Cancer. 1995;75:1619–1626.
31.
GreenwoodMHenritzeJ. Coorscreen: A low-cost, on-site mammography screening program. Am J Health Promot. 1996;10(5):364–370.
32.
BrownMFiremanB. Evaluation of direct medical costs related to cancer. J Natl Cancer Inst.1995;87(6):399–400.
33.
TaplinSBWUrbanNMandelsonMTimlinDIchikawaLNefcyP. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst.1995;87(6):417–426.
34.
GoldfeinKSchneiderWAllegranteJ. Worksite mammography screening; the Morgan Guaranty Trust Company. OpatzJ, ed. Economic Impact of Worksite Health Promotion. Champaign, Ill: Human Kinetics Publishers; 1994:145–157.
35.
GramILundESlenkerSE. Quality of life following a false positive mammogram. Br J Cancer. 1990;62:1018–1022.
36.
LermanCTrockBRimerBK. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med.1991;114:657–661.
37.
ByersTLevinBRothenbergerDDoddGSmithR. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997. CA Cancer J Clin.1997;47: 154–160.
38.
ToribaraNSM. Screening for colorectal cancer. N Engl J Med.1995;332: 861–867.
39.
LiebermanD. Cost-effectiveness model for colon cancer screening. Gastroenterology. 1995;109:1781–1790.
40.
WingoPTongTBoldenS. Cancer statistics 1995. CA Cancer J Clin.1995;45:8–30.
41.
Lu-YaoGMcLerranDWassonJWennbergJ. An assessment of radical prostatectomy: Time trends, geographic variation, and outcomes. JAMA. 1993.
42.
von EschenbachAHoRMurphyGCunninghamMLinsN. American Cancer Society guideline for the early detection of prostate cancer: Update 1997. CA Cancer J Clin.1997;47:261–264.
43.
WolfS. Screening for prostate cancer with prostate-specific antigen. N Engl J Med.1995;333(21):1401–1405.
44.
OptenbergSWojcikBThompsonI. Morbidity and mortality following radical prostatectomy: A national analysis of Civilian Health and Medical Programs of the Uniformed Services beneficiaries. J Urol.1995; 153:1870–1872.
45.
LittrupPGoodmanAMettlinC. The benefit and cost of prostate cancer early detection. CA Cancer J Clin.1993;43(3):134–149.
46.
American Heart Association. AHA Heart and Stroke Facts: 1995 Statistical Supplemental. Dallas, Tex: American Heart Association; 1995.
47.
BronnerLKanterDMansonJ. Primary prevention of stroke. N Engl J Med.1995;333:1392–1399.
48.
National Center for Disease Statistics, National Health and Nutrition Examination Survey. Atlanta, Ga: Centers for Disease Control and Prevention; 1995.
49.
KiiskinenUVartiainenEPekurinenMPuskaP. Does prevention of cardiovascular diseases lead to decreased cost of illness? Twenty years of experience in Finland. Prev Med.1997;26:220–226.
50.
YoungJ. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure. AAOHN. 1995;43(6).
51.
LefebvreRHurseyKCarletonR. Labeling of participants in high blood pressure screening programs: Implications for blood cholesterol screenings. Arch Intern Med.1998;148:1993–97.
52.
HenritzeJBrammellHMcGloinJ. LIFECHECK: A successful low touch, low tech, in-plant cardiovascular disease risk identification and modification program. Am J Health Promot. 1992;7(2):129–136.
53.
The high cost of cardiovascular disease. Behav Health Special Rep.1995; 13(12):6–9.
54.
FooteAErfurtJ. The benefit to cost ratio of work-site blood pressure control programs. JAMA. 1991;265(10):1283–1286.
55.
OldenburgBOwenNParleMGomelM. An economic evaluation of four worksite-based cardiovascular risk factor interventions. Health Educ Q.1995;22(1):9–19.
56.
AldermanMCohenHMadhavenF. Epidemiology of risk in hypertensives: Experience in treated patients. Am J Hypertens. 1998;11 (7):874–876.
57.
PelletierKR. Clinical and cost outcomes of multifactorial cardiovascular risk management interventions in worksites: A comprehensive review and analysis. J Occup Environ Med.1997;39(12):1154–1169.
58.
GoldmanLGordonDRifkindB. Cost and health implications of cholesterol lowering. Circulation. 1992;85:1960–1968.
59.
GlanzKSorensenGFarmerA. Health impact of worksite nutrition and cholesterol intervention programs. Sci Health Promot. 1996;10(6): 453–470.
GreenbergPSteglinLFinkelsteinSBerndtE. The economic impact of depression in 1990. J Clin Psychiatry. 1993;54(11):405–418.
62.
ContiDBurtonW. The economic impact of depression in a workplace. J Occup Med.1994;36(9):983–988.
63.
McCombsJS. The cost of anti-depressant drug therapy failure: A study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry. 1990;51(16 suppl):60–69.
64.
VerboskyLFrancoKZrullJ. The relationship between depression and length of stay in the general hospital patient. J Clin Psychiatry. 1993; 54(5):177–181.
65.
Work-Loss Data Institute. Official Disability Guidelines1998. 3rd ed.Corpus Christi, Tex: Work-Loss Institute, LLC; 1997.
66.
WellsKBStewartALHaysRD. The functioning and wellbeing of depressed patients: Results from the Medical Outcomes Study. JAMA. 1989;262:914–919.
67.
RogersWHWellsKBMeredithLSSturmRBurnamMA. Outcomes for adult depressed outpatients under prepaid or fee-for-service-financing. RAND Draft. 1993 o rch:.
68.
FinderSSmithDix MMcGhanW. Lightening the load of major depression. Business Health. 1996;14(11):67–72.
69.
BroadheadWBlazerDGeorgeLTseC. Depression, disability days, and days lost from work in a prospective epidemiological survey. JAMA. 1990;264(19):2524–2528.
70.
WellsKBStewartALHaysRD. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study. JAMA. 1989;262:914–919.
71.
SimonGEVM. Recognition, management, and outcomes of depression in primary care. Arch Fam Med.1995;4:99–105.
72.
ShephardR. Worksite fitness and exercise programs: A review of methodology and health impact. Am J Health Promot. 1996;10(6):436–452.
73.
ShephardR. Worksite health promotion and productivity. In: KamanR, ed. Worksite Health Promotion Economics: Consensus and Analysis. Champaign, Ill: Association for Worksite Health Promotion; 1995.
74.
ShephardR. A critical analysis of work-site fitness programs and their postulated economic benefits. Med Sci Sports Exerc.1992;24:354–370.
75.
US Department of Health and Human Services. Healthy People 2000 Review 1997. Hyattsville, Md: US Public Health Service; 1997. DHHS publication 98–1256.
76.
US Department of Health and Human Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: US Public Health Service; 1991.
77.
GoetzelRZAndersonDRWhitmerRW. The relationship between modifiable health risks and health care expenditures. J Occup Environ Med.1998;40(10):843–854.
78.
TuckerLAldanaSFriedmanG. Cardiovascular fitness and absenteeism in 8,301 employed adults. Am J Health Promot. 1990;5(2):140–145.
79.
GuoHTanakaSCameronL. Back pain among workers in the United States: National estimates and workers at high risk. Am J Ind Med.1995;28(5):591–602.
80.
FrymoyerJCats-BarilW. An overview of the incidence and cost of low back pain. Orthop Clin North Am.1991;22:263–271.
81.
HashemiLWebsterBClancyEVolinnE. Length of disability and cost of workers' compensation low back pain claims. J Occup Environ Med.1997;39(10):937–945.
82.
GundewallBLiljeqvistMHanssonT. Primary prevention of back symptoms and absence from work. A prospective randomized study among hospital employees. Spine. 1993;18:587–594.
83.
DonchinMWoolfOKaplanL. Secondary prevention of low back pain: A clinical trial. Spine. 1990;15:1317–1320.
84.
The National Health Interview Survey; US, 1988. Hyattsville, Md: 1988(Occupational Health suppl); DHHS publication PHS89–1501.
85.
WebsterBSnookS. The cost of 1989 Workers' Compensation low back pain claims. Spine. 1993;19:1111–1126.
86.
ShiL. A cost-benefit analysis of a California county's back injury prevention program. Public Health Rep.1993;108:204.
87.
Morbidity and Mortality Weekly Report. Medical-care expenditures attributable to cigarette smoking—United States, 1993. JAMA. 1994; 272(6):428–430.
88.
WarnerKSmithRSmithDFriesJ. Health and economic implications of a work-site smoking-cessation program: A simulation analysis. J Occup Environ Med.1996;38(10):981–992.
89.
WoodenMBushR. Smoking cessation and absence from work. Prev Med.1995;24:535–540.
90.
ManningWKeelerENewhouseJSlossFWassermanJ. The Costs of Poor Health Habits. Cambridge, Mass: Harvard University Press; 1991.
91.
HodgsonT. Cigarette smoking and lifetime medical expenditures. Milbank Q.1992;70(1):81–125.
92.
Morbidity and Mortality Weekly Report. Medical-care expenditures attributable to cigarette smoking during pregnancy—United States, 1995. MMWR Morb Mortal Wkly Rep.1997;46(44):1048–1051.
93.
ElixhauserA.The costs of smoking and the cost-effectiveness of smoking cessation programs. J Public Health Policy. 1990;Summer:219–234.
94.
SchoenbornC.Health habits of US adults, 1985: The Alameda seven revisited. Public Health Rep.1986;101 (6):571–580.
95.
EddyD.Eddy ranks the tests. Harv Health Lett.1992;17(special suppl): 10–11.
96.
BarnardNNicholsonAHowardJ. The medical costs attributable to meat consumption. Prev Med.1995;24:646–655.
97.
ByersTMullisRAndersonJDusenburyLGorskyRKimberC. The cost and effects of a nutritional education program following work-site cholesterol screening. Am J Public Health. 1995;85:650–655.
98.
TuckerLFriedmanGM. Obesity and absenteeism: An epidemiologic study of 10,825 employed adults. Am J Health Promot. 1998;12 (3):202–211.
99.
The Surgeon General's Report on Nutrition and Health Summary and Recommendations. R I Med.1988;71 (10):391–401.
100.
WolfAMColditzGA. The cost of obesity: The US perspective. Pharmacoeconomics. 1994;5(suppl):34–37.
101.
BurtonWNChenLTSchultzABEdingtonDW. The economic costs associated with body mass index in a workplace. J Occup Environ Med.1998;40(9):786–792.
102.
DrosteTM. It pays to immunize adults. Business Health Special Rep.1998; September:6–18.
103.
FieldingJCumberlandWPettittL. Immunization status of children of employees in a large corporation. JAMA. 1994;271:525–529.
104.
PinnerRWTeutschSSimonsenL. Trend in infectious disease mortality in the United States. JAMA. 1996;275(3):189–193.
105.
NicholKLindAMargolisK. The effectiveness of vaccination against influenza in healthy, working, adults. N Engl J Med.1995;333(14): 889–893.
106.
BarkerWMulloolyJ. Effectiveness of inactivated influenza vaccine among non-institutionalized elderly persons. KendalAP, ed. Options for the Control of influenza. New York, NY: Alan R. Liss; 1986:169–182.
107.
Centers for Disease Control and Prevention. Recommended childhood immunization schedule, United States, 1997. JAMA. 1997;277(5):371–372.
108.
JacobsonBAldanaSGoetzelRVardellKAdamsTPietrasR. The relationship between perceived stress and self-reported illness-related absenteeism. Am J Health Promot. 1996; 11(1):54–61.
109.
YenLTEdingtonDWWittingP. Associations between health risk appraisal scores and employee medical claims costs in a manufacturing company. Am J Health Promot. 1991;6(1):46–54.
HellmanCJCBuddMABorysenkoJMcClellandDCHerbert. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med.1990;Winter:165–173.
112.
MurphyLR. Stress management in work settings: A critical review of the health effects. Am J Health Promot. 1996;11(2):112–135.
113.
EliashofBAStrelzerJ. The role of “stress” on Workers' Compensation stress claims. J Occup Med.1992;34(3):297–303.
114.
FieldingJE. Worksite stress management: National survey results. J Occup Med.1989;31(12):990–995.
115.
HeaneyAClemansJ. Occupational stress: Physician-excused absences, absences not excused by a physician. Am J Health Promot. 1995;10(2): 117–124.
116.
PelletierKRRodenburgAChikamotoYVintherAKingAFarquharJ. Managing job strain: A randomized controlled trial of an intervention conducted by mail and telephone. Am J Health Promot. 1998;12(3):166–169.
117.
PeterRSiegristJ. Chronic work stress, sickness, absence, and hypertension in middle managers: General or specific sociological explanations?Soc Sci Med.1997;45(7):1111–1120.
118.
RasanenKNotkolaVHusmanK. Perceived work conditions and work-related symptoms among employed Finns. Soc Sci Med.1997;45(7):1099–1110.
119.
ReeseS. Pushing productivity past the breaking point. Business Health. 1997(4):31–34.
120.
SchiffL. Downsizing workplace stress. Business Health. 1997; 15(11):45–46.
121.
ShephardR. Exercise and relaxation in health promotion. Sports Med.1997;23:211–217.
122.
WilsonM. A comprehensive review of the effects of worksite health promotion on health-related outcomes: An update. Am J Health Promot. 1996; 11(2):107–108.
123.
FriesJKoopCBeadleC, Health Project Consortium. Reducing health care costs by reducing need and demand for medical services. N Engl J Med.1993;329(5):321–325.
124.
FriesJHarringtonHEdwardsRKentLRichardsonN. Randomized controlled trial of cost reductions from a health education program: The California Public Employees' Retirement System (PERS) StudyAm J Health Promot. 1994;8(3):216–223.
125.
SchorEStarfieldBStidleyCHankinJ. Family health: Utilization and effects of family membership. Med Care. 1987;25(7):616–626.
126.
SharpeMMayouRSeagroattV. Why do doctors find some patients difficult to help?Q J Med.1994;87(3):187–193.
127.
VickeryDGolaszewskiTWrightEKalmerH. A preliminary study on the timeliness of ambulatory care utilization following medical self-care interventions. Am J Health Promot. 1989;3(3):26–31.
128.
PowellDRBreedlove-WilliamsC. The evaluation of an employee self-care program. Health Values. 1995;19(5):17–22.
129.
NobelJBrodyJ. Telecomputing as a tool to increase consumer participation in managed care. Am J Managed Care. 1996;2(10):1399–1404.
130.
AndersonDR. Database: Research and evaluation results. Am J Health Promot. 1998;13(2):133–138.
131.
PelletierKR. A review and analysis of the health and cost-effective outcome studies of comprehensive health promotion and disease prevention programs. Am J Health Promot. 1991;5(4):311–315.
132.
PelletierKR. A review and analysis of the health and cost-effectiveness outcome studies of comprehensive health promotion and disease prevention programs at the worksite: 1991–1993 update. Am J Health Promot. 1993;8:50–62.
133.
SciaccaJSheehaferRReedRMulvaneyD. The impact of participation in health promotion on medical costs: A reconsideration of the Blue Cross and Blue Shield of Indiana. Am J Health Promot. 1993;7(5): 374–383.
134.
TerborgJ. Computer Simulation: A promising technique for the evaluation of health promotion programs at the worksite. KamanRL, ed. Worksite Health Promotion Economics: Consensus and Analysis. Champaign, Ill: Human Kinetics Publishers; 1995.
135.
RussellL. Is Prevention Better Than Cure?Washington, DC: The Brookings Institute; 1986.
136.
EdingtonDWYenLTWittingP. The financial impact of changes in personal health practices. J Occup Environ Med.1997;39:1037–1046.
137.
LynchWDGolaszewskiTJClearieAFSnowDVickeryDM. Impact of a facility-based corporate fitness program on the number of absences from work due to illness. J Occup Med.1990;32:9–12.
138.
Hastings Center. The goals of medicine: Setting new priorities, an international project of the Hastings Center. Hastings Cent Rep1998;November-December(special suppl):.
139.
GreengardS.Discover best practices through benchmarking. Personnel J.1995:63–73.
140.
GemignaniJ.Best practices that boost productivity. Business Health. 1998; 3:37–42.
141.
O'DonnellMPBishopCAKaplanKL. Benchmarking best practices in worksite health promotion. Am J Health Promot. 1997; 1(1): 1–8.
142.
LeutzingerJRichlingD. Why Union Pacific Railroad's medical self-care program works. AWHP Worksite Health. 1994;Fall:17–22.
143.
BondJGalinskyESwanbergJ. The 1997 National Study of the Changing Workforce. New York, NY: Families and Work Institute; 1998.
144.
EisenbergDM. Unconventional medicine in the United States. N Engl J Med.1993;January:246–252.
145.
AstinJA. Why patients use alternative medicine. JAMA. 1998;279(19): 1548–1554.
146.
Morbidity and Mortality Weekly Report. State-specific prevalence among adults of current cigarette smoking and smokeless tobacco use and per capita tax-paid sales cigarettes—United States, 1997. MMWR Morb Mortal Wkly Rep.1998;47(43);922–926.